Cardiome Pharma Corporation (CRME)
Cardiome Pharma Corporation EBITDA TTM: -25.26M
View CRME EBITDA TTM with YCharts Pro.
Access these YCharts Pro features:
Export any data you want
Save any chart as an image
Utilize advanced screener power
View 30 years of financial history
over 90 advanced calculations
Enjoy an advertising free experience
CRME EBITDA TTM Rankings
| Overall | 5th percentile | 3725 of 3956 |
| Sector | 19th percentile | 406 of 504 in Healthcare |
| Industry | 24th percentile | 31 of 41 in Drug Manufacturers - Other |
CRME EBITDA TTM Range, Past 5 Years
| Minimum | -79.64M | Jun 2008 |
| Maximum | 58.87M | Sep 2010 |
| Average | -18.75M |
About EBITDA (TTM)
EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization. EBITDA (TTM) is the sum of the last four quarters of EBITDA.
Investors often use EBITDA as a starting point for discounted cash flow analysis or to observe the performance of a business separately from its capital structure (debt vs equity financing structure).
Though EBITDA does form an excellent basis for cash flow analysis, some investors argue that it is a misleading measure since depreciation expenses are a real cost - old property, plant and equipment must eventually be replaced if a business plans to continue operations using those assets.
Learn More
You may also be interested in these CRME related companies
CRME News
This company is amazing! A brick is more creative, eloquent and energetic than this $CRME management.
about 10 days ago by OysterX
about 10 days ago by OysterX
Very Interesting One : $CRME ( 0.70 ) This One Will Head Back Over a Buck ! Add On Your Watchlist And Keep An Eye On It ...
about 58 days ago by WallStreetBeats
about 58 days ago by WallStreetBeats
@PIER $CRME I have a feeling it may take a while. could test new lows, though the market hasn't helped.. but its a good buy here
about 60 days ago by peoples
about 60 days ago by peoples
$CRME With Merck calling it quits, is there a possibility that another big player might swoop in? Just wondering.
about 66 days ago by MarketBuy
about 66 days ago by MarketBuy
$CRME Long at .785. Let's go. Merck pullout just a minor setback. PPS is lower than book or cash per share! Easy long!
about 66 days ago by MarketBuy
about 66 days ago by MarketBuy
$CRME they have the cash on hand and it is equal or even more than share price.. its an easy buy
about 68 days ago by peoples
about 68 days ago by peoples
$CRME master at catching a falling knife... and it is not yet... but coming
about 70 days ago by peoples
about 70 days ago by peoples
$CRME I'll let you guys know when to buy.. it is starting to look interesting... sorry for those who thought they are getting in right
about 70 days ago by peoples
about 70 days ago by peoples
Oppenheimer Downgrades Cardiome Pharmaoration from Outperform to Perform, Removes PT from $ to $
Mar 19, 2:25PM Benzinga
Mar 19, 2:25PM Benzinga
$CRME Funny, this morning's plungle probably caused a few heart attacks. Ironic? A little.
about 70 days ago by MarketBuy
about 70 days ago by MarketBuy
Cardiome Announces Positive Phase 1 PK/PD Trial Results for Vernakalant Oral
Nov 03, 5:09PM GlobeNewswire
Nov 03, 5:09PM GlobeNewswire
Cardiome should benefit from significant vernakalant progress, says Oppenheimer
Sep 12, 7:28AM FlyOnTheWall
Sep 12, 7:28AM FlyOnTheWall
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CRME | 0.44 | +0.01 | +2.33% | 26.90M |
| CRMD | 0.27 | -0.01 | -3.50% | 3.081M |
| CRM | 147.00 | +0.79 | +0.54% | 20.14B |
| CRL | 33.56 | +0.21 | +0.63% | 1.641B |
| CPA | 83.85 | +0.62 | +0.74% | 3.713B |
| CP | 74.95 | -0.57 | -0.75% | 12.81B |
| COY | 7.40 | -0.04 | -0.54% | |
| COWN | 2.39 | +0.00 | +0.00% | |
| COVR | 1.54 | +0.00 | +0.00% | 39.42M |
| COV | 53.32 | -0.14 | -0.26% | 25.77B |
